APOE and myeloid sarcoma: As an example, APOE ε4 homozygosity confers a > 90% lifetime risk of developing Alzheimer’s (Liu et al., 2013)—MS has no genetic variation with such a potent effect on disease risk—yet no one argues that APOE ε4 causes Alzheimer’s, only that it strongly modulates the complex processes leading to dementia.